News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
723,108 Results
Type
Article (42894)
Company Profile (439)
Press Release (679774)
Multimedia
Podcasts (90)
Webinars (16)
Section
Business (209540)
Career Advice (2050)
Deals (36105)
Drug Delivery (104)
Drug Development (83816)
Employer Resources (173)
FDA (16555)
Job Trends (15150)
News (354149)
Policy (33265)
Tag
Academia (2655)
Accelerated approval (11)
Adcomms (26)
Allergies (98)
Alliances (51208)
ALS (114)
Alzheimer's disease (1502)
Antibody-drug conjugate (ADC) (168)
Approvals (16535)
Artificial intelligence (330)
Autoimmune disease (33)
Automation (18)
Bankruptcy (373)
Best Places to Work (11849)
BIOSECURE Act (19)
Biosimilars (122)
Biotechnology (331)
Bladder cancer (98)
Brain cancer (35)
Breast cancer (374)
Cancer (2953)
Cardiovascular disease (226)
Career advice (1718)
Career pathing (30)
CAR-T (194)
CDC (32)
Cell therapy (526)
Cervical cancer (22)
Clinical research (68770)
Collaboration (1066)
Company closure (3)
Compensation (699)
Complete response letters (27)
COVID-19 (2691)
CRISPR (64)
C-suite (339)
Cystic fibrosis (118)
Data (3045)
Decentralized trials (2)
Denatured (31)
Depression (70)
Diabetes (351)
Diagnostics (6497)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (146)
Drug pricing (131)
Drug shortages (29)
Duchenne muscular dystrophy (131)
Earnings (89081)
Editorial (45)
Employer branding (21)
Employer resources (149)
Events (117639)
Executive appointments (874)
FDA (18225)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (973)
Gene editing (141)
Generative AI (23)
Gene therapy (407)
GLP-1 (823)
Government (4609)
Grass and pollen (4)
Guidances (181)
Healthcare (19220)
HIV (43)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (164)
Immuno-oncology (8)
Indications (40)
Infectious disease (2868)
Inflammatory bowel disease (155)
Inflation Reduction Act (13)
Influenza (64)
Intellectual property (121)
Interviews (316)
IPO (16900)
IRA (48)
Job creations (3720)
Job search strategy (1456)
Kidney cancer (13)
Labor market (52)
Layoffs (528)
Leadership (20)
Legal (8036)
Liver cancer (80)
Longevity (11)
Lung cancer (413)
Lymphoma (211)
Machine learning (11)
Management (58)
Manufacturing (396)
MASH (94)
Medical device (13632)
Medtech (13637)
Mergers & acquisitions (19927)
Metabolic disorders (885)
Multiple sclerosis (99)
NASH (19)
Neurodegenerative disease (129)
Neuropsychiatric disorders (39)
Neuroscience (2219)
NextGen: Class of 2025 (6766)
Non-profit (4573)
Now hiring (47)
Obesity (451)
Opinion (238)
Ovarian cancer (103)
Pain (112)
Pancreatic cancer (121)
Parkinson's disease (194)
Partnered (22)
Patents (300)
Patient recruitment (169)
Peanut (51)
People (59242)
Pharmaceutical (86)
Pharmacy benefit managers (22)
Phase I (21612)
Phase II (30330)
Phase III (22424)
Pipeline (1654)
Policy (212)
Postmarket research (2613)
Preclinical (9291)
Press Release (67)
Prostate cancer (146)
Psychedelics (43)
Radiopharmaceuticals (273)
Rare diseases (488)
Real estate (6052)
Recruiting (67)
Regulatory (23178)
Reports (50)
Research institute (2439)
Resumes & cover letters (353)
Rett syndrome (9)
RNA editing (10)
RSV (49)
Schizophrenia (94)
Series A (168)
Series B (116)
Service/supplier (11)
Sickle cell disease (66)
Special edition (21)
Spinal muscular atrophy (153)
Sponsored (33)
Startups (3778)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (57)
The Weekly (57)
Vaccines (803)
Venture capital (56)
Weight loss (277)
Women's health (49)
Worklife (17)
Date
Today (73)
Last 7 days (374)
Last 30 days (1933)
Last 365 days (32107)
2025 (17249)
2024 (36348)
2023 (41069)
2022 (52330)
2021 (56799)
2020 (54985)
2019 (47552)
2018 (35785)
2017 (33087)
2016 (32425)
2015 (38484)
2014 (32250)
2013 (27212)
2012 (29364)
2011 (30012)
2010 (28190)
Location
Africa (743)
Alabama (67)
Alaska (7)
Arizona (251)
Arkansas (14)
Asia (39738)
Australia (6591)
California (7600)
Canada (2377)
China (695)
Colorado (328)
Connecticut (333)
Delaware (195)
Europe (86913)
Florida (1123)
Georgia (248)
Hawaii (1)
Idaho (59)
Illinois (660)
India (26)
Indiana (365)
Iowa (18)
Japan (230)
Kansas (111)
Kentucky (30)
Louisiana (15)
Maine (64)
Maryland (1053)
Massachusetts (5744)
Michigan (249)
Minnesota (457)
Mississippi (3)
Missouri (91)
Montana (30)
Nebraska (25)
Nevada (80)
New Hampshire (70)
New Jersey (2115)
New Mexico (30)
New York (2128)
North Carolina (1151)
North Dakota (9)
Northern California (3316)
Ohio (238)
Oklahoma (16)
Oregon (38)
Pennsylvania (1631)
Puerto Rico (17)
Rhode Island (37)
South America (1116)
South Carolina (34)
South Dakota (1)
Southern California (2832)
Tennessee (126)
Texas (1145)
United States (28275)
Utah (222)
Virginia (190)
Washington D.C. (74)
Washington State (657)
West Virginia (4)
Wisconsin (70)
723,108 Results for "y mabs therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Y-mAbs to Host Virtual Radiopharmaceutical R&D Update on May 28, 2025
May 14, 2025
·
3 min read
Press Releases
Y-mAbs Reports First Quarter 2025 Financial Results and Recent Corporate Developments
May 13, 2025
·
21 min read
Press Releases
Y-mAbs to Announce First Quarter 2025 Financial and Operating Results on May 13, 2025
May 7, 2025
·
2 min read
Press Releases
Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline
May 28, 2025
·
10 min read
Press Releases
Y-mAbs Presents GD2-SADA PRIT Trial in Progress Poster at the Advances in Neuroblastoma Research Meeting
May 27, 2025
·
4 min read
Press Releases
Y-mAbs Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Neuroblastoma to Include Naxitamab-gqgk (DANYELZA®)
May 7, 2025
·
7 min read
Business
Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
Y-mAbs Therapeutics, Inc. today announced that Chief Financial Officer, Bo Kruse, has notified the Company of his resignation.
March 14, 2024
·
6 min read
Business
Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Development Officer
Y-mAbs Therapeutics, Inc. announced the appointment of Norman LaFrance, M.D. as Chief Development Officer.
June 5, 2024
·
7 min read
Press Releases
Y-mAbs Announces Publication of Phase 2 Interim Results in Nature Communications
March 3, 2025
·
5 min read
Pharm Country
Y-mAbs to Present at 2024 ASCO Annual Meeting
Y-mAbs Therapeutics, Inc. announced the acceptance of four abstracts at the 2024 American Society of Clinical Oncology Annual Meeting, taking place May 31 – June 4, 2024 in Chicago, IL.
April 25, 2024
·
8 min read
1 of 72,311
Next
